Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Martin Makary
Biotech
FDA debuts priority review voucher with 2-month timeline goal
The FDA “Commissioner’s National Priority Voucher” program includes a limited number of vouchers for “companies aligned with U.S. national priorities."
Gabrielle Masson
Jun 17, 2025 11:59am
At cell and gene roundtable, officials pledge to slash regulations
Jun 5, 2025 2:50pm
FDA launces generative AI tool Elsa a month ahead of schedule
Jun 3, 2025 10:40am
Martin Makary outlines AI plans, broad vision for FDA leadership
May 15, 2025 12:00pm
FDA plans to fully adopt generative AI by end of June
May 8, 2025 1:33pm
19 states sue RFK Jr. over HHS overhaul
May 5, 2025 6:25pm